publication date: Oct. 16, 2020

NCI Director’s Report

Ned Sharpless: “Nothing will stop us”—NCI commemorates 50th anniversary of the National Cancer Act

By Alexandria Carolan

NCI plans to mark the 50th anniversary of the National Cancer Act of 1971 with an effort to build a coalition of support for cancer research, including raising the payline to 15% by 2025.

“With your help, this commemoration can become a movement to coalesce support around our common goals,” NCI Director Ned Sharpless said Oct. 13 during the virtual annual meeting of the Association of American Cancer Institutes and Cancer Center Administrators Forum. “We’d like you to use this framework to talk about your own episodes of progress—how your own cancer centers have contributed to cancer research throughout the decades.”

NCI’s tagline for the campaign—“Nothing will stop us”—will be made available to cancer centers, professional societies, and others. The Cancer Letter will take part in this initiative.

“When I say ‘us,’ I really mean all of us,” Sharpless said. “I really think this is an opportunity for all of us across the research community to clearly say to people with cancer, and the many more whose lives have been touched by cancer, that nothing will stop us in this regard.” 

The 50th anniversary of the National Cancer Act is an important opportunity to sustain public support for cancer research progress, Sharpless said.

“We are commemorating this anniversary by reflecting on our progress for the last five decades and how we got here, and also look at the needs before us—in ways that build our understanding and inspire the next generation of cancer researchers, to see the promise and the potential in … Continue reading Ned Sharpless: “Nothing will stop us”—NCI commemorates 50th anniversary of the National Cancer Act

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.